RETRACTED ARTICLE: p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells
Open Access
- 7 June 2018
- journal article
- expression of-concern
- Published by Springer Nature in BMC Cancer
- Vol. 18 (1) , 641
Abstract
Background: Histone acetyltransferase p300 is a crucial transcriptional coactivator and has been implicated as a poor prognostic factor in human cancers. However, little is known about the substantial functions and mechanisms of p300 in NSCLC proliferation and distant metastasis. Methods: We constructed p300 down-regulated and up-regulated cell lines through RNAi and recombinant plasmid transfection. Cell Counting Kit-8 assays were used to test the cell proliferation and confirmed by colony formation assays. Wound healing assays and transwell chamber assays were used to test the migration and invasion ability. Based upon these results, we measured the epithelial markers and mesenchymal markers after regulating p300 expression to explore epithelial-mesenchymal transition as a potential mechanism of p300 promoting NSCLC metastasis. Results: In NSCLC cells NCI-H1975 and NCI-H1993, down-regulation of p300 leads to inhibition of cell proliferation and colony formation. Cells with reduced p300 expression also demonstrate inhibited migration and invasion ability. Contrarily, up-regulation of p300 significantly enhanced the proliferation, colony formation, migration and invasion ability of NCI-H460. Importantly, further investigation shows that decreased p300 expression is associated with reduced expression of mesenchymal markers and increased expression of epithelial markers, while up-regulated p300 expression correlated with decreased expression of epithelial markers and increased expression of mesenchymal markers. Conclusions: As a crucial tumor promoter, p300 promotes cell proliferation, migration, and invasion in NSCLC cells. Epithelial-mesenchymal transition is a potential mechanism of p300 promoting NSCLC metastasis.Keywords
Funding Information
- National Natural Science Foundation of China (81501986)
- Guangdong Provincial Medical Science Program (2016114134515565)
- Guangdong Provincial Natural Science Foundation Project (2016A030313857)
- Excellent Young Talent Project of Sun Yat-sen University Cancer Center (04140601)
This publication has 27 references indexed in Scilit:
- High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancersEuropean Journal of Surgical Oncology, 2012
- Skp2 expression unfavorably impacts survival in resectable esophageal squamous cell carcinomaJournal of Translational Medicine, 2012
- Selective Roles for cAMP Response Element-binding Protein Binding Protein and p300 Protein as Coregulators for Androgen-regulated Gene Expression in Advanced Prostate Cancer CellsJournal of Biological Chemistry, 2012
- Lung Tumor-associated Osteoblast-derived Bone Morphogenetic Protein-2 Increased Epithelial-to-Mesenchymal Transition of Cancer by Runx2/Snail Signaling PathwayJournal of Biological Chemistry, 2011
- High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinomaJournal of Translational Medicine, 2011
- Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexesProceedings of the National Academy of Sciences, 2009
- Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2Proceedings of the National Academy of Sciences, 2009
- Structural basis for recruitment of CBP/p300 coactivators by STAT1 and STAT2 transactivation domainsThe EMBO Journal, 2009
- p300 expression repression by hypermethylation associated with tumour invasion and metastasis in oesophageal squamous cell carcinomaJournal of Clinical Pathology, 2007
- Roles for the coactivators CBP and p300 and the APC/C E3 ubiquitin ligase in E1A-dependent cell transformationBritish Journal of Cancer, 2006